-
Jointown Pharmaceutical Partners with Shandong DYNE to Boost Pediatric Drug Distribution
•
Jointown Pharmaceutical Group Co., Ltd (SHA: 600998), China’s largest private pharmaceutical distributor, has partnered with Shandong DYNE Marine Biopharmaceutical Co., Ltd., a state-owned firm specializing in pediatric medications. The collaboration aims to integrate Jointown’s nationwide logistics network with DYNE’s R&D expertise in pediatric drugs. Jointown’s Distribution EdgeJointown operates a logistics…
-
Jointown Medical’s COVID-19 Drug Candidate SHEN211 Accepted for Review by NMPA
•
China-based Jointown Medical Devices Group Co., Ltd (SHA: 600998) has announced that its clinical trial filing for the Category 1 COVID-19 drug candidate, SHEN211, has been accepted for review by China’s National Medical Products Administration (NMPA). SHEN211 is an oral broad-spectrum anti-novel coronavirus non-peptide 3CL protease inhibitor, co-developed by a…
